Mini Review
Published on 22 Mar 2013
Targeting the insulin-like growth factor-1 receptor in human cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00030
- 21,797 views
- 88 citations
Type at least 3 characters
21,667 articles
Articles
Mini Review
Published on 14 Mar 2013
Mechanisms and insights into drug resistance in cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00028
- 61,873 views
- 507 citations
Original Research
Published on 13 Mar 2013
Selective Pharmacological Modulation of Pyramidal Neurons and Interneurons in the CA1 Region of the Rat Hippocampus
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00024
- 5,477 views
- 15 citations
Original Research
Published on 13 Mar 2013
Inhibitory Effects of Sigma-2 Receptor Agonists on T Lymphocyte Activation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00023
- 6,826 views
- 12 citations
Original Research
Published on 13 Mar 2013
Polymedication Electronic Monitoring System (POEMS) – a new technology for measuring adherence
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00026
- 8,242 views
- 26 citations
Review
Published on 12 Mar 2013
Cardiotoxicity of Cancer Therapeutics: Current Issues in Screening, Prevention, and Therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00019
- 9,845 views
- 33 citations
Perspective
Published on 11 Mar 2013
Physician Recruitment of Patients to Non-Therapeutic Oncology Clinical Trials: Ethics Revisited
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00025
- 6,990 views
- 5 citations
General Commentary
Published on 06 Mar 2013
PLGA: the smart therapeutics goods carrier
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00020
- 2,906 views
- 1 citation
Review
Published on 06 Mar 2013
Extracellular Vesicles – Biomarkers and Effectors of the Cellular Interactome in Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00021
- 14,049 views
- 165 citations
Original Research
Published on 01 Mar 2013
Exploring the Contribution of Estrogen to Amyloid-Beta Regulation: A Novel Multifactorial Computational Modeling Approach
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00016
- 6,277 views
- 42 citations
Mini Review
Published on 27 Feb 2013
Resistance to PARP-Inhibitors in Cancer Therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00018
- 16,042 views
- 84 citations
Original Research
Published on 18 Feb 2013
Microeconomic Surplus in Health Care: Applied Economic Theory in Health Care in Four European Countries
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00017
- 19,732 views
- 1 citation
Review
Published on 13 Feb 2013
Erlotinib Resistance in Lung Cancer: Current Progress and Future Perspectives
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00015
- 20,779 views
- 50 citations
Review
Published on 12 Feb 2013
Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00013
- 18,545 views
- 79 citations
Mini Review
Published on 12 Feb 2013
The Discovery of Dabigatran Etexilate
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00012
- 20,470 views
- 55 citations
Original Research
Published on 12 Feb 2013
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00009
- 5,403 views
- 4 citations